INOVIO PHARMACEUTICALS, INC. Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale
INOVIO PHARMACEUTICALS, INC. (INO) reported Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale · last filed 2019-03-12
- INOVIO PHARMACEUTICALS, INC. other-than-temporary impairment loss, debt securities, available-for-sale for fiscal 2018 was $0.00.
- INOVIO PHARMACEUTICALS, INC. other-than-temporary impairment loss, debt securities, available-for-sale for fiscal 2017 was $0.00.
| Period end | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale 12 month |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-12 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |